Cargando…
Tarlatamab: a potential new option for recurrent small cell lung cancer
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413042/ https://www.ncbi.nlm.nih.gov/pubmed/37577302 http://dx.doi.org/10.21037/tlcr-23-215 |
| _version_ | 1785087048835661824 |
|---|---|
| author | Addeo, Alfredo Banna, Giuseppe Luigi Friedlaender, Alex |
| author_facet | Addeo, Alfredo Banna, Giuseppe Luigi Friedlaender, Alex |
| author_sort | Addeo, Alfredo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10413042 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104130422023-08-11 Tarlatamab: a potential new option for recurrent small cell lung cancer Addeo, Alfredo Banna, Giuseppe Luigi Friedlaender, Alex Transl Lung Cancer Res Editorial Commentary AME Publishing Company 2023-06-05 2023-07-31 /pmc/articles/PMC10413042/ /pubmed/37577302 http://dx.doi.org/10.21037/tlcr-23-215 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Addeo, Alfredo Banna, Giuseppe Luigi Friedlaender, Alex Tarlatamab: a potential new option for recurrent small cell lung cancer |
| title | Tarlatamab: a potential new option for recurrent small cell lung cancer |
| title_full | Tarlatamab: a potential new option for recurrent small cell lung cancer |
| title_fullStr | Tarlatamab: a potential new option for recurrent small cell lung cancer |
| title_full_unstemmed | Tarlatamab: a potential new option for recurrent small cell lung cancer |
| title_short | Tarlatamab: a potential new option for recurrent small cell lung cancer |
| title_sort | tarlatamab: a potential new option for recurrent small cell lung cancer |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413042/ https://www.ncbi.nlm.nih.gov/pubmed/37577302 http://dx.doi.org/10.21037/tlcr-23-215 |
| work_keys_str_mv | AT addeoalfredo tarlatamabapotentialnewoptionforrecurrentsmallcelllungcancer AT bannagiuseppeluigi tarlatamabapotentialnewoptionforrecurrentsmallcelllungcancer AT friedlaenderalex tarlatamabapotentialnewoptionforrecurrentsmallcelllungcancer |